Carl Maki to Molecular Targeted Therapy
This is a "connection" page, showing publications Carl Maki has written about Molecular Targeted Therapy.
Connection Strength
0.565
-
Novel roles for p53 in the genesis and targeting of tetraploid cancer cells. PLoS One. 2014; 9(11):e110844.
Score: 0.474
-
Pharmacologic activation of p53 by small-molecule MDM2 antagonists. Curr Pharm Des. 2011; 17(6):560-8.
Score: 0.091